183 related articles for article (PubMed ID: 3006754)
21. Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase II.
Zwelling LA; Hinds M; Chan D; Mayes J; Sie KL; Parker E; Silberman L; Radcliffe A; Beran M; Blick M
J Biol Chem; 1989 Oct; 264(28):16411-20. PubMed ID: 2550442
[TBL] [Abstract][Full Text] [Related]
22. Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts.
Zwelling LA; Estey E; Silberman L; Doyle S; Hittelman W
Cancer Res; 1987 Jan; 47(1):251-7. PubMed ID: 3024817
[TBL] [Abstract][Full Text] [Related]
23. Interaction of DNA intercalator 3-nitrobenzothiazolo (3,2-a)quinolinium with DNA topoisomerases: a possible-mechanism for its biological activity.
Báez A; Riou JF; Le Pecq JB; Riou G
Mol Pharmacol; 1990 Mar; 37(3):377-82. PubMed ID: 2156151
[TBL] [Abstract][Full Text] [Related]
24. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II.
Markovits J; Pommier Y; Mattern MR; Esnault C; Roques BP; Le Pecq JB; Kohn KW
Cancer Res; 1986 Nov; 46(11):5821-6. PubMed ID: 3019538
[TBL] [Abstract][Full Text] [Related]
25. Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells.
Markovits J; Pommier Y; Kerrigan D; Covey JM; Tilchen EJ; Kohn KW
Cancer Res; 1987 Apr; 47(8):2050-5. PubMed ID: 3030540
[TBL] [Abstract][Full Text] [Related]
26. Reconstitution of intercalator-induced DNA scission by an active component from nuclear extracts.
Filipski J; Yin J; Kohn KW
Biochim Biophys Acta; 1983 Oct; 741(1):116-22. PubMed ID: 6688534
[TBL] [Abstract][Full Text] [Related]
27. Intercalator-induced, topoisomerase II-mediated DNA cleavage and its modification by antineoplastic antimetabolites.
Zwelling LA; Silberman L; Estey E
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1041-7. PubMed ID: 2427489
[TBL] [Abstract][Full Text] [Related]
28. Absence of a requirement for long-range DNA torsional strain in the production of protein-associated DNA strand breaks in isolated mammalian cell nuclei by the DNA intercalating agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).
Pommier Y; Zwelling LA; Schwartz RE; Mattern MR; Kohn KW
Biochem Pharmacol; 1984 Dec; 33(23):3909-12. PubMed ID: 6548917
[No Abstract] [Full Text] [Related]
29. In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia.
Andersson BS; Beran M; Bakic M; Silberman LE; Newman RA; Zwelling LA
Cancer Res; 1987 Feb; 47(4):1040-4. PubMed ID: 3026621
[TBL] [Abstract][Full Text] [Related]
30. Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.
Tewey KM; Chen GL; Nelson EM; Liu LF
J Biol Chem; 1984 Jul; 259(14):9182-7. PubMed ID: 6086625
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
Nelson EM; Tewey KM; Liu LF
Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1361-5. PubMed ID: 6324188
[TBL] [Abstract][Full Text] [Related]
32. Topoisomerase II mediated DNA lesions induced by acridine-4-carboxamide and 2-(4-pyridyl)quinoline-8-carboxamide.
Woynarowski JM; McCarthy K; Reynolds B; Beerman TA; Denny WA
Anticancer Drug Des; 1994 Feb; 9(1):9-24. PubMed ID: 8141968
[TBL] [Abstract][Full Text] [Related]
33. Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus.
Yamashita Y; Kawada S; Fujii N; Nakano H
Biochemistry; 1991 Jun; 30(24):5838-45. PubMed ID: 1646001
[TBL] [Abstract][Full Text] [Related]
34. The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).
Bakic M; Beran M; Andersson BS; Silberman L; Estey E; Zwelling LA
Biochem Biophys Res Commun; 1986 Jan; 134(2):638-45. PubMed ID: 3004458
[TBL] [Abstract][Full Text] [Related]
35. Cooperative sequestration of m-AMSA in L1210 cells.
Zwelling LA; Kerrigan D; Michaels S; Kohn KW
Biochem Pharmacol; 1982 Oct; 31(20):3269-77. PubMed ID: 6897359
[TBL] [Abstract][Full Text] [Related]
36. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
Ling YH; Andersson BS; Nelson JA
Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
[TBL] [Abstract][Full Text] [Related]
37. A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity.
Barret JM; Calsou P; Larsen AK; Salles B
Mol Pharmacol; 1994 Sep; 46(3):431-6. PubMed ID: 7935322
[TBL] [Abstract][Full Text] [Related]
38. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA
Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033
[TBL] [Abstract][Full Text] [Related]
39. Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials.
Poddevin B; Riou JF; Lavelle F; Pommier Y
Mol Pharmacol; 1993 Oct; 44(4):767-74. PubMed ID: 8232227
[TBL] [Abstract][Full Text] [Related]
40. Cell cycle stage dependent variations in drug-induced topoisomerase II mediated DNA cleavage and cytotoxicity.
Estey E; Adlakha RC; Hittelman WN; Zwelling LA
Biochemistry; 1987 Jul; 26(14):4338-44. PubMed ID: 2822085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
